Editorial Policies
Clear standards for ethics, peer review, and data integrity.
Journal at a Glance
ISSN: 2578-2371
DOI Prefix: 10.14302/issn.2578-2371
License: CC BY 4.0
Peer reviewed open access journal
Scope Alignment
Hepatology, splenology, hepatobiliary disorders, portal hypertension, liver transplantation, metabolic and autoimmune liver disease, imaging, and translational therapeutics. We prioritize validated clinical and mechanistic evidence.
Publishing Model
Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.
JSLR upholds rigorous editorial policies to protect research integrity and ensure reliable hepatology scholarship. We follow international publishing standards for ethics, transparency, and peer review.
- Compliance with human and animal research ethics
- Disclosure of conflicts of interest and funding sources
- Data integrity and reproducibility expectations
- Plagiarism screening and originality checks
JSLR uses single blind peer review. Reviewers evaluate methodology, data quality, and interpretability. Editors ensure feedback is constructive and aligned with journal scope.
Authorship Criteria
Substantial contribution, accountability, and approval by all authors.
Conflict Disclosure
Financial and non financial conflicts must be disclosed.
Data Ownership
Authors must ensure permission to use and share data.
Transparent Methods
Protocols and pipelines should be clearly documented.
- Corrections issued for factual or metadata errors
- Retractions for serious integrity concerns
- Editorial expressions of concern when needed
- Versioning for data or code updates
Authors should disclose AI assisted analysis or writing tools and describe how outputs were validated. Automated outputs must be checked for accuracy, bias, and reproducibility.
Do you allow preprints?
Yes. Disclose preprints and cite them appropriately.
How are conflicts handled?
Editors recuse themselves when conflicts are present.
What happens if data issues arise?
The journal follows COPE guidance for investigations.
- Confirm compliance with COPE guidelines and ethical review standards.
- Disclose conflicts of interest and funding transparency requirements.
- State data sharing expectations and patient consent obligations.
- Outline authorship criteria and contributor role documentation.
- Specify plagiarism screening and similarity check procedures.
- Describe corrections, retractions, and expression of concern workflows.
- Clarify preprint and prior publication policies.
- Document peer review model and reviewer confidentiality expectations.
- Provide guidance on clinical trial registration requirements.
- Describe image integrity checks and manipulation policies.
- Specify requirements for data availability statements.
- Clarify policies on AI assisted writing or analysis disclosures.
- Outline appeal processes for editorial decisions.
- State expectations for reporting adverse events and safety data.
- Describe policies for patient privacy and de identification.
- Provide guidance on protocol deviations and amendments.
- Describe policy for data fabrication or falsification investigations.
- State requirements for clinical trial data sharing statements.
- Clarify image manipulation thresholds and acceptable adjustments.
- Provide policy for duplicate submissions or redundant publication.
- State policy on dual submission to other journals.
- Describe procedures for handling whistleblower reports.
- Clarify expectations for data availability on request.
- Outline responsibilities for corresponding author verification.
- Define policy on image duplication or manipulation screening.
- Describe corrections for metadata or authorship updates.
- Specify requirements for clinical trial registry updates.
- Clarify policy on data citation and repository acknowledgement.
- State policy for reviewer anonymity and confidentiality.
- Provide guidance on reporting of protocol deviations.
- Specify requirements for data availability statements in clinical trials.
- Clarify policy on post publication data corrections.
- Outline procedures for authorship disputes or changes.
- State policy on protocol registration for observational studies.
- Describe requirements for disclosure of sponsor involvement.
- Describe policy for corrections to clinical trial registry information post publication.
JSLR is committed to rigorous, transparent publishing in hepatology and spleen research. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.
The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].
We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in hepatobiliary and gastrointestinal research.
Questions About Policies?
Reach out to the editorial office for clarifications.